Effect of Halofuginone, a Collagen α1(I) Inhibitor, on Wound Healing in Normal and Irradiated Skin: Implication for Hematopoietic Stem Cell Transplantation
- 4 July 2007
- journal article
- research article
- Published by S. Karger AG in Acta Haematologica
- Vol. 118 (2) , 77-83
Abstract
It is a major interest in the field of hematopoietic stem cell transplantation to reduce scarring of healing wounds with overdeposition of collagen due to radiation injury or graft-versus-host disease. Halofuginone (HF) inhibits collagen α1(I) gene expression and overdeposition of collagen. We examined the effect of HF on the healing of full-depth incision wounds inflicted in normal skin or skin areas compromised by local preirradiation with 18 Gy. Preirradiation significantly decreased the tensile strength of the healing wounds at day 14 (by ∼60%, p < 0.0001). In contrast, HF treatment did not significantly decrease the strength of wounds inflicted in both normal and preirradiated skin. Histological evaluation revealed that HF induced moderate thinning of the dermis accompanied by elevated thickness of the epidermis and enhanced rejoining of subdermal muscles in the wound area. HF only minimally reduced total collagen deposition in both groups, with minor changes in the level of more matured fibrillar collagen network. Our study demonstrates that HF does not significantly affect wound strength. This encourages the possible use of HF as an antifibrotic agent with minimal complications for post-hematopoietic stem cell transplantation complications including radiation toxicity and graft-versus-host disease.Keywords
This publication has 27 references indexed in Scilit:
- Molecular and cellular mechanisms of tissue repairExperimental Dermatology, 2005
- Prevention of Esophageal Strictures in a Caustic Burn Model Using Halofuginone, an Inhibitor of Collagen Type I SynthesisThe Laryngoscope, 2005
- The effect of topical tretinoin on tissue strength and skin components in a murine incisional wound modelJournal of the American Academy of Dermatology, 2005
- Amelioration of Radiation-induced FibrosisJournal of Biological Chemistry, 2004
- Halofuginone inhibition of COL1A2 promoter activity via a c‐Jun–dependent mechanismArthritis & Rheumatism, 2002
- THE EFFECT OF HALOFUGINONE, AN INHIBITOR OF COLLAGEN TYPE I SYNTHESIS, ON URETHRAL STRICTURE FORMATION: IN VIVO AND IN VITRO STUDY IN A RAT MODELJournal of Urology, 2000
- Halofuginone: From veterinary use to human therapyDrug Development Research, 2000
- TOPICAL TREATMENT OF CUTANEOUS CHRONIC GRAFT VERSUS HOST DISEASE WITH HALOFUGINONETransplantation, 1999
- Halofuginone: An inhibitor of collagen type I synthesisBiochimica et Biophysica Acta (BBA) - General Subjects, 1993
- Radiosensitivity of capillary endotheliumBritish Journal of Radiology, 1973